Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Answering CSL.com’s survey, the leaders of nonprofit patient organizations said they are looking forward to a productive year…
What’s it like to work in the field? Heintz explains why it’s his favorite part of the job.
Survey sponsored by CSL found gaps in Australians’ understanding of iron deficiency, which is the world’s most common nutriti…
A Duke University expert recommends primary immunodeficiency patients take steps to protect themselves this holiday season. R…
As 2023 comes to a close, leaders in patient advocacy shared accomplishments and highlights in CSL.com’s annual survey.
The Australian scientist is investigating why fighting cancer exhausts T cells, a component of our adaptive immune system.
In a podcast from the Immune Deficiency Foundation, “The Big Sick” co-writer, Emily V. Gordon, shared her experiences navigat…
For its Kankakee location, where rare disease medicines are manufactured, CSL Behring was honored for innovation and operatio…
Vicki Modell, alongside her husband Fred, channeled grief over their son’s death into the Jeffrey Modell Foundation, which ra…
Americas
Asia Pacific
Middle East
Europe
